Foghorn Therapeutics Inc Free Cash Flow Generation Index

Latest as of March 2022: 1.00x

Foghorn Therapeutics Inc free cash flow generation index. Foghorn Therapeutics Inc (FHTX) has a Free Cash Flow Generation Index of 1.00x as of March 2022. Free cash flow of $271.29 Million represents 1% of operating cash flow ($271.53 Million).

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

$271.29 Million
USD

Operating Cash Flow

$271.53 Million
USD

Capital Expenditures

$247.00K
USD

Free Cash Flow Generation Index of Foghorn Therapeutics Inc (2022–2022)

Free cash flow generation index of Foghorn Therapeutics Inc from 2022 to 2022. Historical FCF Generation Index trend for Foghorn Therapeutics Inc across 1 annual periods. See how financially flexible is Foghorn Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.

Foghorn Therapeutics Inc Free Cash Flow Generation Index by Year (2022–2022)

Foghorn Therapeutics Inc free cash flow generation index by year from 2022 to 2022. Year-by-year Free Cash Flow Generation Index for Foghorn Therapeutics Inc. For the full cash flow conversion analysis, see Foghorn Therapeutics Inc cash conversion from operations.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2022 0.99x $192.40 Million $193.61 Million $1.21 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).